Key result
Serum periostin fails to correlate with bone mineral density, while osteocalcin and P1NP predict postmenopausal osteoporosis.
Why the study?
Serum periostin levels are elevated in postmenopausal patients with osteoporotic fractures, but their levels in postmenopausal women with different bone mass remain unclear.
Is serum periostin associated with classical bone turnover markers and bone mineral density in Chinese postmenopausal women?
Cross-Sectional (n=331)
Is serum periostin associated with classical bone turnover markers and bone mineral density in Chinese postmenopausal women?
Serum periostin is not a useful marker of systemic bone metabolism or predictor of osteoporosis in Chinese postmenopausal women without prior fracture.
Answers are grounded in this paper and cite their sources.
Periostin should not guide osteoporosis assessment in postmenopausal women; leaves open the predictive utility of osteocalcin and P1NP in prospective cohorts.
BACKGROUND: It has been reported that serum periostin levels are significantly higher in postmenopausal patients with osteoporotic fractures. Nonetheless, the levels of serum periostin in postmenopausal women with different bone mass remain unclear. PURPOSE: The objective of the study was to identify the levels of serum periostin in Chinese postmenopausal women with different bone mass, and the correlations between the periostin levels and the classical bone turnover markers (BTMs), and bone mineral densities (BMDs) at different sites. PATIENTS AND METHODS: This study enrolled 331 Chinese postmenopausal women in Shanghai; their clinical features were collected; their levels of serum periostin and traditional BTMs were measured by ELISA or the fully automated immunoassay analyzer; their BMDs at different sites were measured by dual-energy X-ray absorptiometry (DXA). There was no significant difference in the serum periostin levels among the above three groups of subjects. In addition, Spearman correlation analysis also revealed that no correlation was observed between the value of serum periostin and those of traditional BTMs, and BMDs at different sites, respectively. The values of traditional BTMs were negatively correlated with those of BMDs at all measured sites. Furthermore, the receiver-operating characteristic (ROC) curves analysis indicated that among the periostin and traditional BTMs mentioned above, the best predictors for postmenopausal osteoporosis in Shanghai Chinese postmenopausal women were osteocalcin (OC) and procollagen type 1 N-terminal propeptide (P1NP) [the areas under the ROC curve (AUC)=0.746 and 0.761, respectively]. CONCLUSION: Serum periostin may not be used as a marker of systemic bone metabolism in Shanghai Chinese postmenopausal women without prior fracture. In addition, serum P1NP and OC levels may be the predictors of osteoporosis occurrence in Chinese postmenopausal women.
No takes yet. Share an insight, caveat, or question.
Ran et al. (2021) conducted a cross-sectional in Postmenopausal osteoporosis (n=331). Serum periostin vs. Normal bone mass, osteopenia, and osteoporosis groups was evaluated on Serum periostin levels across different bone mass groups and correlation with BTMs and BMDs. Serum periostin did not correlate with bone mineral density, whereas osteocalcin and P1NP were the best predictors for postmenopausal osteoporosis.
Synapse has enriched 10 related papers. Consider them for comparative context: